Metabolic system alterations in pancreatic cancer patient serum: potential for early detection

Abstract

The serum metabolome of PC patients is significantly altered. The utility of serum metabolite biomarkers, particularly PC-594, for identifying subjects with elevated risk of PC should be further investigated.